Your browser doesn't support javascript.
loading
Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa.
Boender, T Sonia; Hamers, Raph L; Ondoa, Pascale; Wellington, Maureen; Chimbetete, Cleophas; Siwale, Margaret; Labib Maksimos, Eman E F; Balinda, Sheila N; Kityo, Cissy M; Adeyemo, Titilope A; Akanmu, Alani Sulaimon; Mandaliya, Kishor; Botes, Mariette E; Stevens, Wendy; Rinke de Wit, Tobias F; Sigaloff, Kim C E.
Afiliação
  • Boender TS; Amsterdam Institute for Global Health and Development, Department of Global Health.
  • Hamers RL; Amsterdam Institute for Global Health and Development, Department of Global Health Department of Internal Medicine, Division of Infectious Diseases, Academic Medical Center, University of Amsterdam, The Netherlands.
  • Ondoa P; Amsterdam Institute for Global Health and Development, Department of Global Health.
  • Wellington M; Newlands Clinic, Harare, Zimbabwe.
  • Chimbetete C; Newlands Clinic, Harare, Zimbabwe.
  • Siwale M; Lusaka Trust Hospital.
  • Labib Maksimos EE; Coptic Hospital, Lusaka, Zambia.
  • Balinda SN; Joint Clinical Research Centre, Kampala, Uganda.
  • Kityo CM; Joint Clinical Research Centre, Kampala, Uganda.
  • Adeyemo TA; Department of Haematology & Blood transfusion, College of Medicine of the University of Lagos, Nigeria.
  • Akanmu AS; Department of Haematology & Blood transfusion, College of Medicine of the University of Lagos, Nigeria.
  • Mandaliya K; Coast Province General Hospital, Mombasa, Kenya.
  • Botes ME; Muelmed Hospital, Pretoria.
  • Stevens W; Department of Molecular Medicine and Haematology, University of the Witwatersrand, and the National Health Laboratory Service, Johannesburg, South Africa.
  • Rinke de Wit TF; Amsterdam Institute for Global Health and Development, Department of Global Health.
  • Sigaloff KC; Amsterdam Institute for Global Health and Development, Department of Global Health Department of Internal Medicine, Division of Infectious Diseases, Academic Medical Center, University of Amsterdam, The Netherlands.
J Infect Dis ; 214(6): 873-83, 2016 09 15.
Article em En | MEDLINE | ID: mdl-27402780
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Inibidores da Protease de HIV / Farmacorresistência Viral / Antirretrovirais Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: J Infect Dis Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Inibidores da Protease de HIV / Farmacorresistência Viral / Antirretrovirais Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: J Infect Dis Ano de publicação: 2016 Tipo de documento: Article